The altered distribution of CD4 Th17 cells, identified as a mucosal target cell population for HIV infection, was evident in women using DMPA within a prospective clinical trial of hormonal contraceptive compounds34–36, suggesting an elevated risk of HIV infection. This evidence concerns the gene CD4 and HIV infectious disease.